WallStreetZenWallStreetZen

NYSE: MED
Medifast Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MED

Based on 1 analyst offering 12 month price targets for Medifast Inc

Min Forecast
$12.00-5.44%
Avg Forecast
$12.00-5.44%
Max Forecast
$12.00-5.44%

Should I buy or sell MED stock?

Based on 1 analyst offering ratings for Medifast Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their MED stock forecasts and price targets.

MED stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-02-19

1 of 1

Forecast return on equity

Is MED forecast to generate an efficient return?

Company
-15.68%
Industry
-159.37%
Market
130.61%
MED's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MED forecast to generate an efficient return on assets?

Company
-12.3%
Industry
15.3%
MED is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MED earnings per share forecast

What is MED's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.32
Avg 2 year Forecast
-$2.79

MED revenue forecast

What is MED's revenue in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
$276.4M-20.13%
Avg 2 year Forecast
$249.9M-27.8%
MED's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MED revenue growth forecast

How is MED forecast to perform vs Personal Services companies and vs the US market?

Company
-20.13%
Industry
6.13%
Market
163.62%
MED's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MED's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MED vs Personal Service Stocks

TickerPricePrice TargetUp/downsideConsensus
MED$12.69$12.00-5.44%Hold
WW$11.80$34.50+192.37%Hold
CLIK$2.17N/AN/A
RGS$26.85N/AN/A
PMEC$0.66N/AN/A
View Top Personal Service Stocks

Medifast Stock Forecast FAQ

Is Medifast Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSE: MED) stock is to Hold MED stock.

Out of 1 analyst, 0 (0%) are recommending MED as a Strong Buy, 0 (0%) are recommending MED as a Buy, 1 (100%) are recommending MED as a Hold, 0 (0%) are recommending MED as a Sell, and 0 (0%) are recommending MED as a Strong Sell.

If you're new to stock investing, here's how to buy Medifast stock.

What is MED's earnings growth forecast for 2026-2027?

(NYSE: MED) Medifast's forecast annual earnings growth rate of N/A is not forecast to beat the US Personal Services industry's average forecast earnings growth rate of 16.75%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,294.33%.

Medifast's earnings in 2026 is -$20,022,000.On average, 3 Wall Street analysts forecast MED's earnings for 2026 to be -$3,538,102, with the lowest MED earnings forecast at -$21,575,531, and the highest MED earnings forecast at $15,761,346.

In 2027, MED is forecast to generate -$30,995,645 in earnings, with the lowest earnings forecast at -$30,074,982 and the highest earnings forecast at -$32,223,195.

What is MED's revenue growth forecast for 2026-2027?

(NYSE: MED) Medifast's forecast annual revenue growth rate of -20.13% is not forecast to beat the US Personal Services industry's average forecast revenue growth rate of 6.13%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 163.62%.

Medifast's revenue in 2026 is $346,104,000.On average, 2 Wall Street analysts forecast MED's revenue for 2026 to be $3,073,768,151, with the lowest MED revenue forecast at $2,982,480,216, and the highest MED revenue forecast at $3,195,522,460.

In 2027, MED is forecast to generate $2,778,333,265 in revenue, with the lowest revenue forecast at $2,695,829,432 and the highest revenue forecast at $2,888,412,504.

What is MED's forecast return on assets (ROA) for 2026-2027?

(NYSE: MED) forecast ROA is -12.3%, which is lower than the forecast US Personal Services industry average of 15.3%.

What is MED's Price Target?

According to 1 Wall Street analyst that have issued a 1 year MED price target, the average MED price target is $12.00, with the highest MED stock price forecast at $12.00 and the lowest MED stock price forecast at $12.00.

The Wall Street analyst predicted that Medifast's share price could fall to $12.00 by Feb 19, 2027. The average Medifast stock price prediction forecasts a potential downside of 5.44% from the current MED share price of $12.69.

What is MED's Earnings Per Share (EPS) forecast for 2026-2027?

(NYSE: MED) Medifast's current Earnings Per Share (EPS) is -$1.82. On average, analysts forecast that MED's EPS will be -$0.32 for 2026, with the lowest EPS forecast at -$1.94, and the highest EPS forecast at $1.42. In 2027, MED's EPS is forecast to hit -$2.79 (min: -$2.70, max: -$2.90).

What is MED's forecast return on equity (ROE) for 2026-2027?

(NYSE: MED) forecast ROE is -15.68%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.